Evidence map›Paper›PMID 22714655›Full record

ReviewHuman genetics2012

The role of large pedigrees in an era of high-throughput sequencing.

Ellen M Wijsman

Abstract readReview
In one paragraph

Review in Human genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. A Rare Variant inCancers · 2023
    Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Analysis of high-risk pedigrees identifies 11 candidate variants for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. A Rare Variant inCancers · 2021
    Article
  16. Article
  17. Article
  18. UsingDevelopment (Cambridge, England) · 2020
    Review
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ellen M WijsmanDepartment of Biostatistics, University of Washington, Seattle, WA 98195-7720, USA. wijsman@u.washington.edu

Funding

THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI GRABOWSKI, THOMAS J. · 1985 to 2019
$57.2M
UW Autism Center of ExcellenceP50HD055782 · NICHD · UNIVERSITY OF WASHINGTON · PI KING, BRYAN H · 2007 to 2011
$11.0M
Methods for the Genetic Epidemiology of Complex TraitsR37GM046255 · NIGMS · UNIVERSITY OF WASHINGTON · PI THOMPSON, ELIZABETH ALISON · 2008 to 2017
$4.2M
Next Generation Gene Discovery in Familial AutismR01MH092367 · NIMH · UNIVERSITY OF WASHINGTON · PI BRKANAC, ZORAN · 2011 to 2015
$3.3M
Next Generation Mendelian Genetics in Familial Alzheimer DiseaseR01AG039700 · NIA · UNIVERSITY OF WASHINGTON · PI BRKANAC, ZORAN · 2011 to 2015
$2.9M
THE GENETIC EPIDEMIOLOGY OF COMPLEX TRAITSR01GM046255 · NIGMS · UNIVERSITY OF WASHINGTON · PI THOMPSON, ELIZABETH ALISON · 1991 to 2007
$2.7M
Genetics Contributions to Endophenotypes of DyslexiaR01HD054562 · NICHD · UNIVERSITY OF WASHINGTON · PI RASKIND, WENDY H · 2007 to 2011
$1.8M
NIA NIH HHS AG005136NIA NIH HHS AG039700NIA NIH HHS P50 AG005136NIA NIH HHS R01 AG039700NICHD NIH HHS HD054562NICHD NIH HHS HD055782NICHD NIH HHS P50 HD055782NICHD NIH HHS R01 HD054562NIGMS NIH HHS GM046255NIGMS NIH HHS R01 GM046255NIGMS NIH HHS R37 GM046255NIMH NIH HHS MH092367NIMH NIH HHS R01 MH092367
6 · The paper itself

Abstract

Rare variation is the current frontier in human genetics. The large pedigree design is practical, efficient, and well-suited for investigating rare variation. In large pedigrees, specific rare variants that co-segregate with a trait will occur in sufficient numbers so that effects can be measured, and evidence for association can be evaluated, by making use of methods that fully use the pedigree information. Evidence from linkage analysis can focus investigation, both reducing the multiple testing burden and expanding the variants that can be evaluated and followed up, as recent studies have shown. The large pedigree design requires only a small fraction of the sample size needed to identify rare variants of interest in population-based designs, and many highly suitable, well-understood, and available statistical and computational tools already exist. Samples consisting of large pedigrees with existing rich phenotype and genome scan data should be prime candidates for high-throughput sequencing in the search of the determinants of complex traits.

Indexed as

High-Throughput Nucleotide SequencingPedigreeComputational BiologyGenetic Association StudiesGenetic LinkageGenetic VariationHumans

Identifiers

PMID22714655
PMCPMC3638020

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.